Nature Human Behavior, 4 , 603-612
Since then, thirteen different companies have tried to crack oral insulin
According to publicly disclosed topline results from the Phase 3 EVOKE and EVOKE+ programs data that are currently available only as preliminary announcements and have not yet been fully peer-reviewed or published the trials did not demonstrate clinical efficacy (Athauda et al., 2026)
Sircar et al., 2021).However, the mechanisms underlying the onset of sporadic PD remain unclear, with aging being a primary risk factor (Gundogdu et al., 2021)
The FDA hasnt reviewed it
I've seen too many people choose based on price alone, only to end up with poor results or worsesafety issues